Cuts come as former IBM Americas president Ayman Antoun prepares to take over as CEO. Kitchener-Waterloo-based information management company OpenText has laid off four percent of its global workforce ...

A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...

If you're looking to pre-order Apple's new Studio Display XDR monitor today but have an older Mac, beware of some potential issues. According to the compatibility list spotted by Apple Insider, the ...

In December, Howard Marks published an investment memo titled, “Is it a bubble?” that expressed some of his skepticism and reservations about artificial intelligence and the stock-market boom it had ...

Learn how to build and test narrowboat steps with this companionway tutorial, covering precise measurements, secure installation, and safety checks. Perfect for DIY narrowboat owners aiming to improve ...

This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...

OpenText has named longtime IBM executive Ayman Antoun as its next chief executive, effective April 20. Antoun brings 35 years of experience to the Waterloo, Ontario-based enterprise software company, ...

Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...

OpenText™ is a global leader in secure information management for AI, helping organizations protect, govern, and activate their data with confidence. Our technologies turn data into information with ...

💇‍♀️ Testing INH hair extensions—full review plus styling tutorial included! #HairExtensions #INHReview #BeautyTutorial Here's what an Epstein files vote in the House could look like Off-duty pilot ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...